How microbes are rewriting the rules of immunity – Howard Hang, PhD
October 8, 2025
How do microbes influence our immune system, and can we leverage this relationship to combat disease? In this free Front Row lecture, Scripps Research Professor Howard Hang delved into his lab’s innovative work at the intersection of chemistry, microbiology and immunology. By dissecting the molecular dialogues between gut bacteria and human cells, Hang’s research uncovers how microbial enzymes generate small molecules—called microbial metabolites—that can influence immune responses. These insights are paving the way for new treatments against infections, cancer and inflammatory illnesses, highlighting the powerful role that microbes play in shaping human health.
Expanding the drug target universe – Benjamin Cravatt, PhD
September 17, 2025
There are countless proteins that play critical roles in disease, yet they remain challenging to target with therapeutics. In this free Front Row lecture, professor Benjamin Cravatt explained how his large-scale protein profiling research and innovative chemical technologies are helping identify novel drugs for therapeutic targets previously deemed ‘undruggable.’ Cravatt’s translational work, which is at the intersection of chemistry and biology, has also led to the formation of multiple local biotechnology companies that collectively employ hundreds of scientists who are developing first-in-class candidate medicines for diverse diseases ranging from cancer to neurological disorders.
Reprogramming the immune system: A new era of precision immunotherapy for cancer and autoimmune disease – Travis Young, PhD
August 20, 2025
Your immune system is your body’s natural defense, capable of identifying what belongs and what doesn’t. But when it falters, it can let cancer grow unchecked or mistakenly attack your own healthy tissues, leading to autoimmune diseases. What if we could reprogram the immune system to tip the balance in our favor, gaining an advantage over both cancers and autoimmune disorders? In this free Front Row lecture, Calibr-Skaggs’ vice president of biologics, Travis Young, will share how Scripps Research is using genetic engineering to reprogram patients’ own immune cells to create personalized “switchable” CAR-T cell therapies. This approach represents a new class of precision immunotherapy designed to induce deep and durable remissions in patients with a wide range of cancers, from lymphoma to breast cancer, as well as in chronic autoimmune conditions such as lupus, rheumatoid arthritis and systemic sclerosis. Young will explain how this breakthrough strategy works and what it could mean for the future of medicine.
The science of longer, healthier lives: Eric Topol, MD
May 21, 2025
How close are we to a future where aging is no longer a barrier to vitality? Scripps Research executive vice president and professor Eric Topol will discuss the themes of his new book on longevity. Drawing on the latest breakthroughs, he’ll explore how innovations in artificial intelligence and drug discovery are combating chronic diseases like cancer, diabetes and neurodegeneration. Topol will reveal how these advances are not only extending lifespans but also improving health at every stage of life.
Regenerative medicine for the treatment of MS: Enhancing repair to prevent progression: Luke Lairson, PhD
April 16, 2025
Multiple sclerosis (MS) is a debilitating autoimmune disease that disrupts the central nervous system, causing symptoms like muscle weakness, cognitive challenges and a gradual loss of function that current treatments cannot fully repair. MS arises when the immune system attacks the myelin sheath, the protective layer insulating neurons. Scripps Research chemistry professor Luke Lairson will discuss his research on the body’s natural repair pathways—specifically those that activate endogenous stem cells to restore myelin. His work aims to develop therapies that complement existing therapeutic approaches and halt MS progression.
Decoding viruses for vaccine innovation: Andrew Ward, PhD
March 19, 2025
Viruses use specialized proteins to infect human cells, and understanding their structure is key to creating more effective vaccines and antiviral therapies. Scripps Research professor Andrew Ward will delve into his pioneering work on mapping these proteins with cutting-edge imaging techniques. Ward’s research provides critical insights into viral neutralization mechanisms, paving the way for advancements in vaccine development against pathogens like HIV, influenza, coronaviruses and much more.
The gut-brain axis: A key to metabolism and longevity: Supriya Srinivasan, PhD
February 26, 2025
How do our gut and brain communicate with one another, and how do they influence our metabolism, our behavior, and the aging process? Scripps Research neuroscience professor Supriya Srinivasan is dedicated to answering these pressing questions using modern genetic and molecular tools across different experimental systems. Srinivasan will reveal the intricacies of the gut-brain networks that regulate energy regulation and fat metabolism, as well as their impact on lifespan. Discover how her work could lead to new therapies that restore a healthy metabolism and tackle dysregulation.